Details: 60 min web-assisted phone interview Please sign up at the link below to receive an email invite to the survey. Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …
Rare Patient Voice: Non-Small Cell Lung Cancer Patients
Study Details: 60 min Web-Assisted phone Interview Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! …
Rare Patient Voice: Study Opportunity for Lung Cancer Patients – African American / Ages 50 – 75
Study Details: 60 min Web-Assisted Phone Interview Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! …
Rare Patient Voice: Study Opportunity for Prostate, Lung & Blood Cancer Patients
Study Details: 25 minute Online Survey Compensation $45 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …
Rare Patient Voice: Study Opportunity for Multiple Cancer Types
Study Details: Cancer patients with any of the following cancer types: Breast Prostate Skin (Melanoma and Basal Cell) Bladder Kidney Lung 60 min Online Bulletin Board US patients only Compensation $100 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you …
Lung Screening Bus Brings High-Tech Health Care Directly to Patients
Source: The Society of Thoracic Surgeons From: prnewswire.com First-of-Its-Kind Vehicle Helps Diagnose Lung Cancer and Incidental Heart Disease A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher, …
FDA Approves Novartis’ Capmatinib, Foundation Medicine CDx for Metastatic NSCLC
By: Staff Reporter From: genomeweb.com The US Food and Drug Administration on Wednesday approved capmatinib (Novartis’ Tabrecta) for treatment of patients with metastatic non-small cell lung cancer. The agency also approved Foundation Medicine’s FoundationOne CDx assay, a broad comprehensive genomic profiling test for solid tumors, as a companion diagnostic for the drug. A companion diagnostic for capmatinib with Foundation’s liquid …
Breast Cancer and Atrial Fibrillation
By: Kayla Matthews From: news-medical.net Atrial fibrillation (AFib) is a common heart rhythm problem whereby the heart’s two upper chambers, the atria, squeeze out of sync and often rapidly. This causes the heart’s walls to quiver. Numerous factors, such as age, high blood pressure, overactive thyroid, and viral infections can put people at a higher risk for developing atrial fibrillation. …
Janssen Pharmaceutical Bispecific Antibody Granted Breakthrough Designation for Lung Cancer Treatment
By: Staff Reporter From: precisiononcologynews.com Janssen Pharmaceutical Companies, a unit of Johnson & Johnson, said on Tuesday that its investigational drug JNJ-61186372 (JNJ-6372) has been granted breakthrough therapy designation by the US Food and Drug Administration. The drug is being evaluated in non-small cell lung cancer patients with EGFR exon 20 insertion mutations whose disease has progressed on or after …
Immune discovery ‘may treat all cancer’
By: James Gallagher From: bbc.com A newly-discovered part of our immune system could be harnessed to treat all cancers, say scientists. The Cardiff University team discovered a method of killing prostate, breast, lung and other cancers in lab tests. The findings, published in Nature Immunology, have not been tested in patients, but the researchers say they have “enormous potential”. Experts …